Permanent Q-Code for ARMLUPEG®

Permanent HCPCS Code

Q5169

Injection, pegfilgrastim-unne (armlupeg), biosimilar, 0.5 mg

Code Effective

July 1, 2026

Commercially Available

October 1, 2026

Effective July 1, 2026, Valorum Biologics' Armlupeg^® has received a permanent HCPCS code: Q5169. Armlupeg is a biosimilar to Neulasta^® (pegfilgrastim) and should not be billed using the reference product or other biosimilar HCPCS codes.

Valorum Biologics requests your partnership in updating all systems and locations with the correct HCPCS and NDC information for Q5169 to ensure accurate billing and reimbursement.

Note to Providers: Armlupeg will be available to order from your wholesaler or distributor beginning October 1st.

Armlupeg HCPCS Information

HCPCS Code

Q5169

HCPCS Descriptor

Injection, pegfilgrastim-unne (armlupeg), biosimilar, 0.5 mg

Manufacturer

Valorum Biologics LLC

NDC Code*

70748-0273-01

NDC Package Description

Armlupeg PFS 6 mg/0.6 mL Prefilled Syringe, 1 ct

WAC per Package

$6,097.08

WAC per HCPCS Unit

$508.09

*The above 11-digit NDC code for Valorum Biologics' Armlupeg is used for claims processing and reimbursement. The 10-digit NDC code is 70748-273-01.

Please see Armlupeg full Prescribing Information.